161 related articles for article (PubMed ID: 2661480)
1. Cellular pharmacology of fluorinated pyrimidines in vivo in man.
Kovach JS; Beart RW
Invest New Drugs; 1989 Apr; 7(1):13-25. PubMed ID: 2661480
[TBL] [Abstract][Full Text] [Related]
2. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
3. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
[TBL] [Abstract][Full Text] [Related]
4. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
5. 5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma.
Cao S; Rustum YM; Spector T
Cancer Res; 1994 Mar; 54(6):1507-10. PubMed ID: 8137256
[TBL] [Abstract][Full Text] [Related]
6. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
Iigo M; Hoshi A
Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
Cao S; Rustum YM
Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
[TBL] [Abstract][Full Text] [Related]
8. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxic effect between serine-threonine phosphatase inhibitors and 5-fluorouracil: a novel concept for modulation of cytotoxic effect.
Islam MM; Begum S; Lin L; Okamura A; Du M; Fujimura S
Cancer Chemother Pharmacol; 2002 Feb; 49(2):111-8. PubMed ID: 11862424
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
Sobrero AF; Aschele C; Bertino JR
J Clin Oncol; 1997 Jan; 15(1):368-81. PubMed ID: 8996164
[TBL] [Abstract][Full Text] [Related]
11. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaks.
Waxman S; Huang Y; Scher BM; Scher M
Biomed Pharmacother; 1992; 46(5-7):183-92. PubMed ID: 1467447
[TBL] [Abstract][Full Text] [Related]
13. Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model.
Cao S; Lu K; Tóth K; Slocum HK; Shirasaka T; Rustum YM
Clin Cancer Res; 1999 Feb; 5(2):267-74. PubMed ID: 10037174
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphate.
Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
Cancer Chemother Pharmacol; 1987; 20(1):1-4. PubMed ID: 3040286
[TBL] [Abstract][Full Text] [Related]
15. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
Rich TA; Shepard RC; Mosley ST
J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.
Miller AA; Moore EC; Hurlbert RB; Benvenuto JA; Loo TL
Cancer Res; 1983 Jun; 43(6):2565-70. PubMed ID: 6189583
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil radiation sensitization--a brief review.
Byfield JE
Invest New Drugs; 1989 Apr; 7(1):111-6. PubMed ID: 2661479
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem.
Machover D; Goldschmidt E; Mollicone R; Haghighi-Rad F; Desterke C; Gaston-Mathé Y; Saffroy R; Boucheix C; Dairou J
J Pharmacol Exp Ther; 2018 Aug; 366(2):238-243. PubMed ID: 29858389
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil and the new oral fluorinated pyrimidines.
Kuhn JG
Ann Pharmacother; 2001 Feb; 35(2):217-27. PubMed ID: 11215843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
